Eleftheria Atalla, MD

🚨 Breakthrough research 🚨 From my co-fellow @JonesColton242 and @LSOM_HemOnc reshaping the landscape for metabolic health + cancer prevention. The incident of colorectal cancer among users of GLP-1RAs was 36% lower than the observed among aspirin users #ColorectalCancer #GLP1RA

In untreated chronic lymphocytic leukemia, fixed-duration venetoclax-based regimens were noninferior to continuous ibrutinib with regard to 3-year progression-free survival and were associated with higher MRD-negative rates. Full phase 3 CLL17 trial results and Research Summary: nejm.org/doi/full/10.10…

"You have to focus on what you can do." Life advice from 2023 medicine laureate Katalin Karikó who is encouraging us all to focus on things that are within our control and pay less attention to what we can't control. For more life advice and to hear her life story, watch our full interview with her: youtu.be/X-jLB2cbdB8

Big news!! #mmsm Tec-Dara gets FDA approval. fda.gov/news-events/pr… @IMFmyeloma @theMMRF @HealthTree

Happy Thank A Fellow Day! We are so thankful for our hem/onc fellows and all that they do! We had a pizza and cookie party followed by a walk through the park led by Dr. Karnad! @DrSAHaddad @EllieAtalla @theglpman @mayscancer

Along with weight loss, a new study found taking a GLP-1 may also lower your risk of colon cancer. Colton Jones, MD, lead author of the study and a hematology and oncology fellow at UT San Antonio, spoke with @KENS5 about the results: bit.ly/4rnaXMM

Cleveland is lucky to have you my friend 🙌🙌

Oncology and hematology experts from across the country are in San Antonio for the 28th annual #PANAO — highlighting practice-changing advances in cancer care and a keynote from Daniel D. Von Hoff, MD. There’s still time to register for Day Two: bit.ly/49JYxH3

Interesting discussion with lymphoma expert Dr. Chavez from @MayoClinic Valuable insights into the evolving therapeutics for R/R DLBCL and follicular lymphomas @LSOM_HemOnc @mayscancer

Our fellows attending the Practical Applications of New Agents in Oncology Conference (PANO) in San Antonio! @mayscancer @DrSAHaddad @EllieAtalla @JayParekhhh @RadhaKannaiyan @HemOncFellows

What an honor to learn from the renowned Dr. Daniel Von Hoff—former leader at Mays Cancer Center, and a true pioneer in translational research and early-phase drug development for pancreatic cancer! @LSOMFaculty1st @mayscancer

Happy holidays from our hem/onc fellows! We had a blast decorating gingerbread houses with our PD! @KateIdaLathrop @AggieMD @EllieAtalla @DrSAHaddad @OscarAndreHino1 @AnumjalilMD @HemOncFellows

Congrats to our hem/onc fellows who presented @SABCSSanAntonio! We had several spotlight oral presentations and poster presentations. We are so proud of all your accomplishments! #SABCS25 @DanielaUruetamd @DrSAHaddad @mayscancer @HemOncFellows

@EllieAtalla demonstrates the OS impact when MCL patients are treated in Academic Centers @mayscancer @UTHealthSA #ASH25 @Grupo_GELL

Grateful to my mentor, Dr Diaz @AEDiazMD for the guidance and for supporting my first #ASH25 🩸 ✨ @LSOM_HemOnc @mayscancer

🧬 PARADIGM trial: is this the end of 7+3?? 🤯 #ASH25 @ASH_hematology

🚨 Greek mythology alert golcodamide (oral CELMoD agent designed for degradation of Ikaros and Aiolos) +rituximab in R/R DLBCL #ASH25 @ASH_hematology

🧬 Exciting times for aggressive lymphoma treatment 🙌: Smart Stop Trial by Dr Westin @MDAndersonNews #ASH25

Kicking off Day 1 of #ASH2025 🔬🩸 Today was all about learning—new science, new perspectives, and so many take-aways already 🙌 @LSOM_HemOnc @mayscancer @HemOncFellows

Happy Fellowsgiving from our Hem/Onc fellows to yours! Great afternoon filled w/ food and gratitude! Huge s/o to our PD Dr. Lathrop for all you do for our fellowship and cooking an incredible meal! @DrSAHaddad @EllieAtalla @AggieMD @AnumjalilMD @OscarAndreHino1 @JonesColton242